These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2334572)

  • 1. Development of ploidy and cell proliferation in serial samples of ascites from patients with ovarian carcinoma.
    Sahni K; Tribukait B; Einhorn N
    Acta Oncol; 1990; 29(2):193-7. PubMed ID: 2334572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric measurement of ploidy and proliferation in effusions of ovarian carcinoma and their possible prognostic significance.
    Sahni K; Tribukait B; Einhorn N
    Gynecol Oncol; 1989 Nov; 35(2):240-5. PubMed ID: 2807018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of proportion of S-phase cells in ascites and pleural effusions in ovarian carcinoma using antibromodeoxyuridine monoclonal antibody and DNA flow-cytometry.
    Sahni K; Tribukait B; Einhorn N
    Acta Oncol; 1989; 28(5):705-8. PubMed ID: 2590547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry.
    Rotmensch J; Atcher RW; Schwartz JL; Grdina DJ
    Gynecol Oncol; 1992 Jan; 44(1):10-2. PubMed ID: 1730415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ploidy assessment of benign and malignant ovarian tumors by flow cytometry. A clinicopathologic study.
    Iversen OE; Skaarland E
    Cancer; 1987 Jul; 60(1):82-7. PubMed ID: 3581034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic significance of tumor cell ploidy in advanced ovarian carcinoma].
    Novik VI; Gevorkian VA; Maksimov SIa
    Vopr Onkol; 2006; 52(1):54-8. PubMed ID: 16715704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.
    Kaern J; Tropé CG; Kristensen GB; Pettersen EO
    Cancer; 1994 Apr; 73(7):1870-7. PubMed ID: 8137213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian and endometrial endometrioid carcinoma: diagnostic implications of flow cytometry.
    Vassilev NB; Christov KT; Raychev RD
    Neoplasma; 1986; 33(1):57-62. PubMed ID: 3960210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular DNA content--a stable feature in epithelial ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Tattersall MH
    Br J Cancer; 1984 Feb; 49(2):173-9. PubMed ID: 6696818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer.
    Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R
    Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
    Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
    Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of tumor ploidy in patients with advanced ovarian carcinoma.
    Khoo SK; Hurst T; Kearsley J; Dickie G; Free K; Parsons PG; Whitaker S; Ward B
    Gynecol Oncol; 1990 Dec; 39(3):284-8. PubMed ID: 2258072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of pregnancy complicated with ovarian endometrioid carcinoma].
    Suzuki M; Owada M; Tamada T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):825-8. PubMed ID: 6736729
    [No Abstract]   [Full Text] [Related]  

  • 17. Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction.
    Leminen A; Paavonen J; Vesterinen E; Forss M; Wahlström T; Kulomaa P; Lehtinen M
    Am J Obstet Gynecol; 1990 Mar; 162(3):848-53. PubMed ID: 2316596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers.
    Ohyama S; Yonemura Y; Miyazaki I
    Cancer; 1990 Jan; 65(1):116-21. PubMed ID: 2293858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.